Literature DB >> 19347669

Evaluating and managing neonatal acute renal failure in a resource-poor setting.

Tinuade A Ogunlesi1, Folasade Adekanmbi.   

Abstract

Acute renal failure (ARF) is encountered in neonatal care where it may be associated with significant morbidities. Pre-renal failure, which is due to impaired renal tissue perfusion, is the commonest type of ARF. It is amenable to treatment with excellent prognosis following prompt diagnosis and timely institution of appropriate intervention. Unfortunately, ARF in the newborn is usually asymptomatic and it is only suspected when a newborn infant has not been observed to pass urine over several hours or when serum Creatinine is observed to be elevated or rising. In resource-poor settings, it is often difficult to conduct detailed evaluation of suspected cases of newborn ARF due to lack of appropriate equipments and infrastructure. Similarly, therapeutic facilities are sparse and there is heavy reliance on conservative management of cases. Such difficulties encountered in the evaluation and management of newborns with ARF in most parts of the developing world, like Nigeria, where diagnostic and therapeutic facilities are limited are highlighted.

Entities:  

Mesh:

Year:  2009        PMID: 19347669     DOI: 10.1007/s12098-009-0055-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  23 in total

1.  Acute renal failure in the newborn: incidence and outcome.

Authors:  A Airede; M Bello; H D Weerasinghe
Journal:  J Paediatr Child Health       Date:  1997-06       Impact factor: 1.954

2.  Acute renal failure in neonatal sepsis.

Authors:  N B Mathur; Himanshu S Agarwal; Arti Maria
Journal:  Indian J Pediatr       Date:  2006-06       Impact factor: 1.967

3.  Factors associated with mortality in acute renal failure (ARF) in children.

Authors:  Reyner Loza; Luis Estremadoyro; César Loza; Javier Cieza
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

4.  Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001.

Authors:  Shirley Hui-Stickle; Eileen D Brewer; Stuart L Goldstein
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

Review 5.  Management of acute renal failure in the newborn.

Authors:  Nadeem E Moghal; Nicholas D Embleton
Journal:  Semin Fetal Neonatal Med       Date:  2006-04-03       Impact factor: 3.926

Review 6.  [Postnatal management of urinary tract anomalies after antenatal diagnosis].

Authors:  C Grapin; F Auber; P de Vries; G Audry; P Helardot
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2003-06

7.  Continuous renal replacement therapy in children up to 10 kg.

Authors:  Jordan M Symons; Patrick D Brophy; Melissa J Gregory; Nancy McAfee; Michael J G Somers; Timothy E Bunchman; Stuart L Goldstein
Journal:  Am J Kidney Dis       Date:  2003-05       Impact factor: 8.860

8.  Indomethacin and renal impairment in neonates.

Authors:  Satoshi Akima; Alison Kent; Graham J Reynolds; Martin Gallagher; Michael C Falk
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

9.  Paediatric acute peritoneal dialysis in southern Nigeria.

Authors:  I C Anochie; F U Eke
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

10.  Renal failure in Nigerian children: factors limiting access to dialysis.

Authors:  Wasiu Adekunle Olowu
Journal:  Pediatr Nephrol       Date:  2003-10-29       Impact factor: 3.714

View more
  2 in total

1.  Acute kidney injury in a single neonatal intensive care unit in Turkey.

Authors:  Fatih Bolat; Serdar Comert; Guher Bolat; Oznur Kucuk; Emrah Can; Ali Bulbul; Hasan Sinan Uslu; Asiye Nuhoglu
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

2.  Recognition and management of acute kidney injury in children: The ISN 0by25 Global Snapshot study.

Authors:  Etienne Macedo; Jorge Cerdá; Sangeeta Hingorani; Jiayi Hou; Arvind Bagga; Emmanuel Almeida Burdmann; Michael Rocco V; Ravindra Mehta L
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.